Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites.
about
The Role of Bioactive Dietary Components in Modulating miRNA Expression in Colorectal CancerThe role of p53 in cancer drug resistance and targeted chemotherapyDose-Independent ADME Properties and Tentative Identification of Metabolites of α-Mangostin from Garcinia mangostana in Mice by Automated Microsampling and UPLC-MS/MS MethodsAlpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells.Dietary α-mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in mice.Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence.Intestinal microbial dysbiosis and colonic epithelial cell hyperproliferation by dietary α-mangostin is independent of mouse strain.α-Mangostin Improves Glucose Uptake and Inhibits Adipocytes Differentiation in 3T3-L1 Cells via PPARγ, GLUT4, and Leptin Expressions.The use of natural products in colorectal cancer drug discovery.In vitro assessment of anti-proliferative effect induced by α-mangostin from Cratoxylum arborescens on HeLa cells.α-Mangostin: anti-inflammatory activity and metabolism by human cellsα-mangostin: one of the best dietary supplements.Beta-mangostin from Cratoxylum arborescens activates the intrinsic apoptosis pathway through reactive oxygen species with downregulation of the HSP70 gene in the HL60 cells associated with a G0/G1 cell-cycle arrest.Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice.Usage, biological activity, and safety of selected botanical dietary supplements consumed in the United States.
P2860
Q28070764-2EE57E27-B74E-48F3-A3CD-CF3FCC07B54EQ28072553-DB56F239-C823-44EE-A38B-4DE56DA3CDB3Q28546533-F1340B5F-6BB7-4E60-B52E-381057C3E9C9Q33765134-1EBC3B21-D223-4111-9F56-AAB54C9CBB09Q33824770-F9AB150C-7864-4C9A-826C-81DC4140105EQ34655382-FCACA105-9970-45F0-A30D-CA8CE24BD8D4Q35131286-2FC9720E-5AC2-4C8B-BFB6-88B38B04B959Q35271424-F2E84A7D-B332-4327-A15A-A2DFAA15E16CQ35569158-D69BE2A2-E527-48A0-9196-20233FC2E399Q38696434-3C6B97BF-1F0A-4A57-99B3-1346EAF47238Q39167884-D8C23698-612E-4CD8-9BD8-1A2D19EB9CEFQ44136065-A7D352EA-F76D-4DBE-80BA-367A86E14C97Q46267150-B017A0E3-B2BF-4BD7-8E6C-8601D9B14F03Q51074606-ECCA9825-EDD8-4383-9952-F3CDD50E5EDAQ55045913-EFBD41B0-7C29-4006-A95C-6800B20A2790
P2860
Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-tumorigenicity of dietary ...... nd their phase II metabolites.
@en
Anti-tumorigenicity of dietary ...... nd their phase II metabolites.
@nl
type
label
Anti-tumorigenicity of dietary ...... nd their phase II metabolites.
@en
Anti-tumorigenicity of dietary ...... nd their phase II metabolites.
@nl
prefLabel
Anti-tumorigenicity of dietary ...... nd their phase II metabolites.
@en
Anti-tumorigenicity of dietary ...... nd their phase II metabolites.
@nl
P2093
P2860
P50
P356
P1476
Anti-tumorigenicity of dietary ...... and their phase II metabolites
@en
P2093
Chureeporn Chitchumroonchokchai
Jannarin Nontakham
Mark L Failla
Steven K Clinton
Sunit Suksumrarn
P2860
P304
P356
10.1002/MNFR.201200539
P577
2012-12-13T00:00:00Z